state_POLICY

STATE POLICY

Delaware is home to a thriving and diverse bioscience community. More than 8,000 Delawareans are employed in this industry, with an average annual wage of six figures.

Institutions including Delaware State University, the University of Delaware, Christiana Care Health System, and Nemours Children’s Health System conduct groundbreaking research in the bioscience realm. Bioscience companies in our state range in size from tiny startups, to mid-sized companies, to large enterprises employing hundreds, but they are all vitally important in their innovative contributions.

In addition to our annual Luncheon at Legislative Hall , Delaware Bio engages year-round with the State of Delaware administration and state legislators on issues directly relevant to our state's industry. Examples include:

  • Significant advocacy engagement which resulted in unanimous passage of Senate Substitute 1 for Senate Bill 118, allowing for the substitution of interchangeable biologic medicines (also referred to as biosimilars). Delaware was the first state of many to institute such legislation.
  • Meeting with the Delaware House Small Business Caucus to discuss policies present in other states, that help budding bioscience companies prosper, innovate, and create jobs.
  • Testifying for the 2016 Delaware Commitment to Innovation Act (SB 200), which incentivized companies to establish global headquarters in Delaware. This legislation also made the R&D tax credit refundable and removed the annual cap, so that groundbreaking startups can receive crucial capital while they conduct research and development.
  • Advocating for funds in the Governor’s budget to be allocated towards specific bioscience industry initiatives.
  • Encouraging the state to support policies aimed at improving Science, Technology, Engineering, and Math (STEM) educational and workforce development efforts, such as the BioGENEius program.

Click here to learn about the Delaware General Assembly & find your local legislators